NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada (MDC). Each year MDC presents their esteemed Dr David Green Awards to groups and individuals who have shown exceptional commitment to improving the lives of Canadians affected by NMDs. We are honored to receive the Excellence in Service Delivery Award for 2024 and are excited to continue working with MDC and the entire Canadian neuromuscular community to fulfill our network mission to improve the care, research, and treatment of NMDs for all Canadians.
NMD4C Investigators Receiving a Dr. David Green Award
As an academic research network, we rely on the incredible team of investigators who are the driving force behind our work and are thrilled to see several NMD4C investigators receive individual awards recognizing their contributions to the neuromuscular community! Congratulations to Dr Jodi Warman Chardon, Dr Erin O’Ferrall, and Dr Cam-Tu Émilie Nguyen, who each received a Dr David Green Award:
Dr Jodi Warman-Chardon, recipient of the 2024 Dr George Karpati Award for Researcher of the Year
Dr Erin O’Ferrall, recipient of the Outstanding Healthcare Partner Award
Dr Cam-Tu Émilie Nguyen, recipient of the Rising Clinician/Researcher Award
Read the full news release from MDC to see the full list of award winners!.
Read next...
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.
MICYRN Secures $20 Million Grant from CIHR for a Pediatric Rare Disease Clinical Trials and Treatment Network
The NMD4C are excited to share that MICYRN’s success in securing a $20 million grant from CIHR Institute of Genetics to support the development and execution of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network.